Wróć

Wybierz swój region

Corporate

Europa:

Flaga Albania Albania Flaga Bośnia i Hercegowina Bośnia i Hercegowina Flaga Bułgaria Bułgaria Flaga Chorwacja Chorwacja Flaga Cypr Cypr Flaga Czarnogóra Czarnogóra Flaga Czechy Czechy Flaga Dania Dania Flaga Estonia Estonia Flaga Hiszpania Hiszpania Flaga Kosowo Kosowo Flaga Litwa Litwa Flaga Łotwa Łotwa Flaga Luksemburg Luksemburg Flaga Macedonia Macedonia Flaga Niemcy Niemcy Flaga Polska Polska Flaga Portugalia Portugalia Flaga Rumunia Rumunia Flaga Serbia Serbia Flaga Słowacja Słowacja Flaga Słowenia Słowenia Flaga Szwajcaria Szwajcaria Flaga Szwecja Szwecja Flaga Turcja Turcja Flaga Ukraina Ukraina Flaga Węgry Węgry Flaga Wielka Brytania Wielka Brytania Flaga Włochy Włochy

Azja:

Flaga UAE UAE Flaga Hong Kong Hong Kong Flaga Kuwejt Kuwejt Flaga Liban Liban

Afryka:

Flaga RPA RPA

Umów konsultację o krwi pępowinowej

Umawiam

Skontaktuj się z nami już dziś!

Chcesz dowiedzieć się więcej o naszych usługach? Uzupełnij poniższy formularz, a my skontaktujemy się z Tobą jak najszybciej, aby udzielić Ci wszelkich potrzebnych informacji oraz odpowiedzieć na Twoje pytania.

    Uprzejmie informujemy, że dane osobowe podane w formularzu będą przetwarzane przez Polski Bank Komórek Macierzystych Sp. z o.o. („PBKM”) z siedzibą w Warszawie, Al. Jana Pawła II 29 w celu kontaktu telefonicznego w związku z udzieleniem informacji na temat usługi.

    Zestawienie leczonych pacjentów

    Zestawienie
    leczonych pacjentów

    Tabela pacjentów

    Lp.
    Źródło
    Typ źródła
    Wskazanie
    Obszar medycyny
    Rok podania
    Terapia
    Kraj
    Wiek odbiorcy
    Wszystko
    Wszystko
    Wszystko
    Wszystko
    Wszystko
    Wszystko
    Wszystko
    Wszystko
    1
    Cord Tissue
    Allogeneic - Related
    Chronic renal disease
    Endocrinology
    2025
    Experimental Therapy
    Romania
    50
    2
    Cord Tissue
    Allogeneic - Related
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    6
    3
    Cord Tissue
    Autologous
    Autism
    Neurology
    2025
    Experimental Therapy
    Romania
    6
    4
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedy
    2025
    Experimental Therapy
    Poland
    57
    5
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    3
    6
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    3
    7
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    2
    8
    Cord Tissue
    Allogeneic - Unrelated
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    5
    9
    Cord Tissue
    Allogeneic - Unrelated
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Poland
    11
    10
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedics
    2025
    Experimental Therapy
    Poland
    54
    11
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedics
    2025
    Experimental Therapy
    Poland
    78
    12
    Cord Tissue
    Allogeneic - Unrelated
    Autism
    Neurology
    2025
    Experimental Therapy
    Poland
    6
    13
    Cord Tissue
    Allogeneic - Unrelated
    Degenerative and traumatic cartilage damage
    Orthopedics
    2025
    Experimental Therapy
    Poland
    58
    14
    Cord Blood
    Allogeneic - Related
    Thalassemia Major
    Hematology
    2025
    Standard Therapy
    Turkey
    5
    15
    Cord Blood
    Autologous
    Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    2
    16
    Cord Blood
    Allogeneic - Related
    Thalassemia Major
    Hematology
    2025
    Standard Therapy
    Turkey
    6
    17
    Cord Blood
    Allogeneic - Related
    Cerebral Palsy
    Neurology
    2025
    Experimental Therapy
    Portugal
    1
    18
    Bone Marrow Family
    Allogeneic
    Myelofibrosis
    Hematology
    2025
    Standard Therapy
    Poland
    71
    19
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    United Kingdom
    72
    20
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    France
    47
    21
    Bone Marrow Family
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Ukraine
    43
    22
    Bone Marrow Family
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    49
    23
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    France
    51
    24
    Bone Marrow Family
    Allogeneic
    Philadelphia - positive Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    61
    25
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    France
    58
    26
    Bone Marrow Family
    Allogeneic
    Myelofibrosis
    Hematology
    2025
    Standard Therapy
    NETHERLANDS
    63
    27
    Bone Marrow Family
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    65
    28
    Bone Marrow Family
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    France
    63
    29
    Bone Marrow Family
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Poland
    68
    30
    Bone Marrow
    Allogeneic
    Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Spain
    15
    31
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Norway
    55
    32
    Bone Marrow
    Allogeneic
    Inherited Immune System Disorder
    Hematology
    2025
    Standard Therapy
    France
    3
    33
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    7
    34
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Ukraine
    36
    35
    Bone Marrow
    Allogeneic
    Inherited Immune System Disorder
    Hematology
    2025
    Standard Therapy
    France
    10
    36
    Bone Marrow
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    USA
    76
    37
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    39
    38
    Bone Marrow
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    South Africa
    6
    39
    Bone Marrow
    Allogeneic
    Wiskott-Aldrich syndrome
    Hematology
    2025
    Standard Therapy
    Turkey
    6
    40
    Bone Marrow
    Allogeneic
    Combined immnunodeficiency
    Hematology
    2025
    Standard Therapy
    Ukraine
    3
    41
    Bone Marrow
    Allogeneic
    Chronic Granulomatous Disease
    Hematology
    2025
    Standard Therapy
    Poland
    3
    42
    Bone Marrow
    Allogeneic
    Mixed Phenotype Acute Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    13
    43
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    7
    44
    Bone Marrow
    Allogeneic
    B-cell precursor Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    56
    45
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    43
    46
    Bone Marrow
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Poland
    19
    47
    Bone Marrow
    Allogeneic
    Very Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    12
    48
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    5
    49
    Bone Marrow
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    10
    50
    Bone Marrow
    Allogeneic
    Severe Aplastic Anemia
    Hematology
    2025
    Standard Therapy
    Poland
    6
    51
    Bone Marrow
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    44
    52
    Bone Marrow
    Allogeneic
    Paroxysmal Nocturnal Hemoglobinuria
    Hematology
    2025
    Standard Therapy
    Poland
    25
    53
    Bone Marrow
    Allogeneic
    Juvenile Myelomonocytic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    4
    54
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    58
    55
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    34
    56
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    61
    57
    Apheresis
    Allogeneic
    Myelodysplastic Syndrome/Myeloproliferative neoplasm
    Hematology
    2025
    Standard Therapy
    NETHERLANDS
    62
    58
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Austria
    68
    59
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    70
    60
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    66
    61
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    77
    62
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Ukraine
    12
    63
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    58
    64
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    67
    65
    Apheresis
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    4
    66
    Apheresis
    Allogeneic
    Myelofibrosis Myeloid Metaplasia
    Hematology
    2025
    Standard Therapy
    USA
    73
    67
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    56
    68
    Apheresis
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    50
    69
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    39
    70
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Lithuania
    43
    71
    Apheresis
    Allogeneic
    Chronic Myelomonocytic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    66
    72
    Apheresis
    Allogeneic
    Multiple Myeloma
    Hematology
    2025
    Standard Therapy
    USA
    61
    73
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Austria
    55
    74
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    69
    75
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Denmark
    67
    76
    Apheresis
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    United Kingdom
    75
    77
    Apheresis
    Allogeneic
    T - cell Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Poland
    24
    78
    Apheresis
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    Belgium
    68
    79
    Apheresis
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    Ukraine
    42
    80
    Apheresis
    Allogeneic
    Acute Lymphoblastic Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    50
    81
    Apheresis
    Allogeneic
    Prolymphocytic Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    62
    82
    Apheresis
    Allogeneic
    Myelodysplastic Syndrome
    Hematology
    2025
    Standard Therapy
    United Kingdom
    62
    83
    Apheresis
    Allogeneic
    Chronic Myelomonocytic Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    69
    84
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    85
    85
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    54
    86
    Apheresis
    Allogeneic
    Non-Hodgkin Lymphoma
    Hematology
    2025
    Standard Therapy
    USA
    39
    87
    Apheresis
    Autologous
    Multiple myeloma
    Hematology
    2025
    Standard Therapy
    Germany
    45
    88
    Apheresis
    Autologous
    Acute myeloid leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    59
    89
    Apheresis
    Allogeneic
    Multiple myeloma
    Hematology
    2025
    Standard Therapy
    Germany
    68
    90
    Apheresis
    Allogeneic
    Multiple myeloma
    Hematology
    2025
    Standard Therapy
    Germany
    68
    91
    Apheresis
    Autologous
    Multiple myeloma
    Hematology
    2025
    Standard Therapy
    Germany
    73
    92
    Apheresis
    Autologous
    Multiple myeloma
    Hematology
    2025
    Standard Therapy
    Germany
    66
    93
    Apheresis
    Autologous
    Acute myeloid leukemia
    Hematology
    2025
    Standard Therapy
    Germany
    69
    94
    Apheresis
    Autologous
    Hodgkin lymphoma
    Hematology
    2025
    Standard Therapy
    Germany
    38
    95
    Apheresis
    Allogeneic
    Tcell acute leukemia
    Hematology
    2025
    Standard Therapy
    Romania
    31
    96
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Italy
    37
    97
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    Sweden
    69
    98
    Apheresis
    Allogeneic
    Acute Myelogenous Leukemia
    Hematology
    2025
    Standard Therapy
    USA
    55
    99
    Apheresis
    Allogeneic
    Fanconi's Anemia
    Hematology
    2025
    Standard Therapy
    Russia
    14
    100
    Apheresis
    Allogeneic
    Peripheral T-cell Lymphoma not otherwise specified
    Hematology
    2025
    Standard Therapy
    Germany
    54
    Strona
    z76
    100 pozycji
    Ładowanie